Equillium (EQ) Notes Payables (2020 - 2023)
Equillium's (EQ) quarterly Notes Payables came in at $5.7 million in Q1 2023, up 100.0% year-on-year from $2.9 million in Q1 2022, and little changed on a QoQ basis from $5.7 million in Q4 2022.
Equillium (EQ) Notes Payables (2020 - 2023) Analysis & Trends
Equillium (EQ) has 4 years of Notes Payables data on file, last reported at $5.7 million in Q1 2023.
- On a quarterly basis, Notes Payables rose 100.0% year-over-year to $5.7 million in Q1 2023; TTM through Mar 2023 was $5.7 million, a 100.0% increase from a year earlier, with the FY2022 full-year figure at $5.7 million, up 300.14% from the prior year.
- Notes Payables for Q1 2023 stood at $5.7 million, roughly flat from $5.7 million in the prior quarter.
- Over the last five years, Notes Payables for EQ reached as high as $5.7 million in Q3 2022 and fell as low as $833000.0 in Q3 2020.
- Historically, Notes Payables has averaged $3.2 million across 4 years, with a median of $2.7 million in 2021.
- Across the five-year window, Notes Payables dropped 14.29% in 2021 and soared 357.12% in 2022, its largest moves.
- Year by year, Notes Payables stood at $1.7 million in 2020, then dropped by 14.29% to $1.4 million in 2021, then soared by 300.14% to $5.7 million in 2022, then changed by 0.0% to $5.7 million in 2023.
- Per Business Quant data, the three most recent Notes Payables figures were $5.7 million in Q1 2023, $5.7 million in Q4 2022, and $5.7 million in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Equillium | 242.14 Mn | 242.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 5.71 Mn |
| Dec 31, 2022 | 5.71 Mn |
| Sep 30, 2022 | 5.71 Mn |
| Jun 30, 2022 | 4.29 Mn |
| Mar 31, 2022 | 2.86 Mn |
| Dec 31, 2021 | 1.43 Mn |
| Sep 30, 2021 | 1.25 Mn |
| Mar 31, 2021 | 2.50 Mn |
| Dec 31, 2020 | 1.67 Mn |
| Sep 30, 2020 | 833,000.00 |